The successful candidate will serve as the translational and biomarker lead for assigned programs, partnering closely with Discovery Research, Clinical Development, Clinical Pharmacology, Precision Medicine, Bioinformatics, Biostatistics, Regulatory Affairs, Diagnostics, Medical Affairs, and external collaborators to accelerate biomarker-driven drug development and enable data-driven clinical decision making. Working knowledge of modern translational technologies, including: next-generation sequencing (NGS), RNA sequencing, ctDNA, multiplex immunohistochemistry, digital pathology, proteomics, flow cytometry, single-cell technologies, emerging multi-omics approaches/data integration and computational biology.